Hudson Bay Capital Management’s NRX Pharmaceuticals Warrant NRXPW Stock Holding History

Hudson Bay Capital Management’s Portfolio NRXPW Stock Details NRXPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-187,500	Closed	-$84K	–	608
2020 Q2	$84K	Hold	187,500	–	–	﹤0.01%	462
2020 Q1	$13K	Hold	187,500	–	–	﹤0.01%	464
2019 Q4	$30K	Hold	187,500	–	–	﹤0.01%	406
2019 Q3	$38K	Hold	187,500	–	–	﹤0.01%	386
2019 Q2	$44K	Buy	+187,500	New	+$33.2K	﹤0.01%	393

Other funds holding NRXPW

BFM

Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return

VAS

VR Advisory Services Camana Bay, Grand Cayman, Cayman Islands $845M AUM 22.79% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.95% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Hudson Bay Capital Management's NRXPW Position: Q3 2020 in Review

Hudson Bay Capital Management sold out of NRX Pharmaceuticals Warrant (NRXPW) in Q3 2020, closing a stake of 187,500 shares — an estimated $84K sold.

Hudson Bay Capital Management first reported a position in NRXPW in Q2 2019 and held it in 5 quarters. The position peaked at $84K in Q2 2020. 13 funds tracked by Wall St. Rank hold NRXPW as of Q3 2020.

Hudson Bay Capital Management reported no remaining NRX Pharmaceuticals Warrant position as of Q3 2020 after selling out during the quarter.
Hudson Bay Capital Management sold 187,500 NRX Pharmaceuticals Warrant shares in Q3 2020, an estimated $84K.
Hudson Bay Capital Management first reported a position in NRX Pharmaceuticals Warrant in Q2 2019 and held it in 5 quarters.
Hudson Bay Capital Management's NRX Pharmaceuticals Warrant position peaked at $84K in Q2 2020.
13 funds tracked by Wall St. Rank held NRX Pharmaceuticals Warrant as of Q3 2020.

Based on Hudson Bay Capital Management's 13F filing for Q3 2020, filed 12 Nov 2020.